Clinical trial • Phase III • Oncology
ADP-A2M4CD8 for Urothelial cancer|Esophageal cancer|Gastric cancer|Non-small cell lung cancer|Head and neck cancer|Ovarian cancer|Melanoma|Endometrial cancer
Phase III trial of ADP-A2M4CD8 for Urothelial cancer|Esophageal cancer|Gastric cancer|Non-small cell lung cancer|Head and neck cancer|Ovarian cancer|Melan…
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Urothelial cancer|Esophageal cancer|Gastric cancer|Non-small cell lung cancer|Head and neck cancer|Ovarian cancer|Melanoma|Endometrial cancer
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 08-05-2024
- First CTIS Authorization Date
- 23-05-2024
Trial design
Phase III trial across 9 sites in Spain.
- Target Sample Size
- 88
Eligibility
Recruits 88 Vulnerable population selected; no further details on consent or assent handling are provided in the available records..
- Vulnerable Population
- Vulnerable population selected; no further details on consent or assent handling are provided in the available records.
Recruitment
- Planned Sample Size
- 88
- Recruitment Window Months
- 128
Geography
- Total Number Of Sites
- 9
- Total Number Of Participants
- 32
Spain
- Earliest CTIS Part Ii Submission Date
- 02-05-2024
- Latest Decision Or Authorization Date
- 23-05-2024
- Processing Time Days
- 21
- Number Of Sites
- 9
- Number Of Participants
- 32
Sites
- Site Name
- University Hospital Virgen Del Rocio S.L.
- Department Name
- Oncology
- Contact Person Name
- Reyes Bernabe Caro
- Contact Person Email
- bernabeensayos@gmail.com
- Site Name
- Institut Catala D'oncologia
- Department Name
- Oncology
- Contact Person Name
- Marc Oliva Bernal
- Contact Person Email
- moliva@iconcologia.net
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Contact Person Name
- Victor Moreno Garcia
- Contact Person Email
- victor.moreno@startmadrid.com
- Site Name
- Clinica Universidad De Navarra
- Department Name
- Oncology
- Contact Person Name
- Mariano Ponz Sarvise
- Contact Person Email
- mponz@unav.es
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology
- Contact Person Name
- Elena Garralda Cabanas
- Contact Person Email
- egarralda@vhio.net
- Site Name
- Hospital Clinico Universitario De Valencia
- Department Name
- Oncology
- Contact Person Name
- Andres Cervantes
- Contact Person Email
- andres.cervantes@uv.es
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology
- Contact Person Name
- Emiliano Calvo Aller
- Contact Person Email
- emiliano.calvo@startmadrid.com
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Oncology
- Contact Person Name
- Jon Zugazagoitia Fraile
- Contact Person Email
- j.zugazagoitia.imas12@h12o.es
- Site Name
- Hospital Universitario 12 De Octubre (additional entry)
- Department Name
- Oncology
- Contact Person Name
- Jon Zugazagoitia Fraile
- Contact Person Email
- j.zugazagoitia.imas12@h12o.es
Sponsor
Primary sponsor
- Full Name
- USWM Ct LLC
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Investigational products
- Investigational Product Name
- ADP-A2M4CD8
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)